Max Healthcare moves up as its arm acquires additional equity stake in Starlit Medical Centre
Max Healthcare Institute is currently trading at Rs. 1029.40, up by 1.45 points or 0.14% from its previous closing of Rs. 1027.95 on the BSE.
The scrip opened at Rs. 1019.95 and has touched a high and low of Rs. 1034.00 and Rs. 982.50 respectively. So far 18064 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 1227.50 on 08-Jan-2025 and a 52 week low of Rs. 695.40 on 29-Jan-2024.
Last one week high and low of the scrip stood at Rs. 1097.95 and Rs. 982.50 respectively. The current market cap of the company is Rs. 99760.19 crore.
The promoters holding in the company stood at 23.74%, while Institutions and Non-Institutions held 72.48% and 3.77% respectively.
Max Healthcare Institute’s wholly-owned subsidiary -- Crosslay Remedies (Crosslay) has completed acquisition of additional equity stake for consideration up to Rs 150 crore by way of subscribing to rights issue of Starlit Medical Centre (Starlit), wholly-owned subsidiary of Crosslay.
Earlier, board of directors of Crosslay, in meeting held on August 1, 2024 had approved the same.
Max Healthcare Institute offers healthcare services through its various facilities in Delhi and the National Capital Region, and facilities in Mohali and Bathinda.
